Skip to main content
SpringerLink
Log in

Understanding PK/PD

  • Understanding the Disease
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Udy AA, Varghese JM, Altukroni M, Briscoe S, McWhinney B, Ungerer J, Lipman J, Roberts JA (2012) Sub-therapeutic initial beta-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. Chest 142:30–39

    Article  CAS  PubMed  Google Scholar 

  2. Blot S, Lipman J, Roberts DM, Roberts JA (2014) The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary? Diagn Microbiol Infect Dis 79:77–84

    Article  CAS  PubMed  Google Scholar 

  3. Jamal JA, Economou CJ, Lipman J, Roberts JA (2012) Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation. Curr Opin Crit Care 18:460–471

    Article  PubMed  Google Scholar 

  4. Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J (2014) DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58:1072–1083

    Article  CAS  PubMed  Google Scholar 

  5. Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, Hope WW, Farkas A, Neely MN, Schentag JJ, Drusano G, Frey OR, Theuretzbacher U, Kuti JL (2014) Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis 14:498–509

    Article  PubMed  PubMed Central  Google Scholar 

  6. Valenza G, Seifert H, Decker-Burgard S, Laeuffer J, Morrissey I, Mutters R (2012) Comparative activity of carbapenem testing (COMPACT) study in Germany. Int J Antimicrob Agents 39:255–258

    Article  CAS  PubMed  Google Scholar 

  7. Blot S, Koulenti D, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J, Roberts JA (2014) Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study. Crit Care 18:R99

    Article  PubMed  PubMed Central  Google Scholar 

  8. Roberts JA, Stove V, De Waele JJ, Sipinkoski B, McWhinney B, Ungerer JP, Akova M, Bassetti M, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J (2014) Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI Study. Int J Antimicrob Agents 43:423–430

    Article  CAS  PubMed  Google Scholar 

  9. Sinnollareddy M, Roberts JA, Lipman J, Akova M, Bassetti M, De Waele JJ, Kaukonen K-M, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Dimopoulos G (2015) Pharmacokinetic variability and exposures of fluconazole, anidulafungin and caspofungin in intensive care unit patients: data from multinational defining antibiotic levels in intensive care unit (DALI) patients Study. Crit Care 19:33

    Article  PubMed  PubMed Central  Google Scholar 

  10. Rayner CR, Forrest A, Meagher AK, Birmingham MC, Schentag JJ (2003) Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme. Clin Pharmacokinet 42:1411–1423

    Article  CAS  PubMed  Google Scholar 

  11. Forrest A, Nix DE, Ballow CH, Goss TF, Birmingham MC, Schentag JJ (1993) Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 37:1073–1081

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Li C, Du X, Kuti JL, Nicolau DP (2007) Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections. Antimicrob Agents Chemother 51:1725–1730

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Tam VH, McKinnon PS, Akins RL, Rybak MJ, Drusano GL (2002) Pharmacodynamics of cefepime in patients with Gram-negative infections. J Antimicrob Chemother 50:425–428

    Article  CAS  PubMed  Google Scholar 

  14. Beumier M, Casu GS, Hites M, Wolff F, Cotton F, Vincent JL, Jacobs F, Taccone FS (2015) Elevated beta-lactam concentrations associated with neurological deterioration in ICU septic patients. Minerva Anestesiol 81:497–506

    CAS  PubMed  Google Scholar 

  15. Roberts JA, Taccone FS, Udy AA, Jacobs F, Louis J-L, Lipman J (2011) Vancomycin dosing in critically ill patients—robust methods for improved continuous infusion regimens. Antimicrob Agents Chemother 55:2704–2709

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

J.A. Roberts is funded by a Career Development Fellowship from the National Health and Medical Research Council of Australia (APP1048652).

Author information

Authors and Affiliations

  1. Burns Trauma and Critical Care Research Centre, School of Medicine, Royal Brisbane and Women’s Hospital, The University of Queensland, Level 3 Ned Hanlon Building, Butterfield St, Brisbane, QLD, 4029, Australia

    Jason A. Roberts & Jeffrey Lipman

  2. Department of Intensive Care Medicine, The Royal Brisbane and Women’s Hospital, Brisbane, QLD, Australia

    Jason A. Roberts & Jeffrey Lipman

  3. Department of Pharmacy, The Royal Brisbane and Women’s Hospital, Brisbane, QLD, Australia

    Jason A. Roberts

  4. Department of Intensive Care, Erasme Hospital, Universite Libre de Bruxelles, Brussels, Belgium

    Fabio Silvio Taccone

  5. Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia

    Jeffrey Lipman

Authors
  1. Jason A. Roberts
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fabio Silvio Taccone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeffrey Lipman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jason A. Roberts.

Ethics declarations

Conflicts of interest

None of the authors are aware of any actual or potential conflicts of interest associated with this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Roberts, J.A., Taccone, F.S. & Lipman, J. Understanding PK/PD. Intensive Care Med 42, 1797–1800 (2016). https://doi.org/10.1007/s00134-015-4032-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-015-4032-6

Keywords

Search

Navigation